Apremilast Sandoz eco 10 mg / 20 mg / 30 mg

Apremilast Sandoz eco 10 mg / 20 mg / 30 mg is a medicine authorised by Swissmedic under authorisation number 70469. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 June 2026 and the authorisation is limited until 28 June 2031. ATC code L04AA32 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 70469
  • ATC L04AA32
  • Synthetic medicines
Authorisation data
Authorisation number70469
NameApremilast Sandoz eco 10 mg / 20 mg / 30 mg
Full nameApremilast Sandoz eco 10 mg / 20 mg / 30 mg, Filmtabletten
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeL04AA32
First authorisation29 June 2026
Authorisation validity28 June 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Apremilast Sandoz eco 10 mg / 20 mg / 30 mg, FilmtablettenB29 June 2026
2Apremilast Sandoz eco 30 mg, FilmtablettenB29 June 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
14+4+19Tablette(n)L04AA3207.15.0.B
256Tablette(n)L04AA3207.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Apremilast Sandoz eco 10 mg / 20 mg / 30 mg authorised in Switzerland?

Yes. Apremilast Sandoz eco 10 mg / 20 mg / 30 mg is authorised by Swissmedic under authorisation number 70469, data as of 01 September 2026. The authorisation is limited until 28 June 2031.

Which dispensing category does Apremilast Sandoz eco 10 mg / 20 mg / 30 mg have?

Apremilast Sandoz eco 10 mg / 20 mg / 30 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Apremilast Sandoz eco 10 mg / 20 mg / 30 mg?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com